Aptevo Therapeutics
APVO
APVO
6 hedge funds and large institutions have $22.8K invested in Aptevo Therapeutics in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
-3
Holders Change %
-33.33%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Geode Capital Management
Boston,
Massachusetts
|
+$12.2K |
2 |
CS
Clear Street
New York
|
+$3.25K |
3 |
Bank of America
Charlotte,
North Carolina
|
+$2.69K |
4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.53K |
5 |
SS
SBI Securities
Tokyo,
Japan
|
+$650 |
Top Sellers
1 |
VF
Virtu Financial
New York
|
-$93K |
2 |
HF
HRT Financial
New York
|
-$53K |
3 |
![]()
JPMorgan Chase & Co
New York
|
-$19.5K |
4 |
DP
Diadema Partners
Morristown,
New Jersey
|
-$17.5K |
5 |
Morgan Stanley
New York
|
-$16.9K |